The pharmaceutical landscape for diabetes is changing, and transdermal GLP-1 delivery systems represent a exciting breakthrough. Unlike shots, this method offers a less invasive way to deliver GLP-1 drugs. These https://stevewipv441507.theideasblog.com/41439816/glp-1-patches-a-novel-approach-to-blood-sugar-treatment